(1 - 8 von 11
)
MD Anderson Department Chair Richard E. Champlin, M.D. Joins ...www.actiniumpharma.com › press-releases › detail
www.actiniumpharma.com
· Champlin, M.D. of MD Anderson Cancer Center to its Scientific Advisory Board (SAB) for Iomab™-B, the Company's lead radioimmunotherapy asset ...Es fehlt: BECTON, DICKINSON · Champlin, M.D. of MD Anderson Cancer Center to its Scientific Advisory Board (SAB) for Iomab™-B, the Company's lead radioimmunotherapy asset ... Es fehlt: BECTON, DICKINSON
sortiert nach Relevanz / Datum